The size of the European Cannabidiol Market is projected to witness a robust CAGR between 2021 to 2026.
The legalization of the cultivation of cannabis in most of the countries in Europe is certainly a major factor for the market to grow. CBD oils have many health benefits, especially in treating cancer tumor cells. This is ascribed to bolster the growth rate of the market. Cannabidiol also has various advantages in the industries such as textiles, pharmaceuticals, and others, which is also to elevate the demand of the market to the extent. Increasing incidences of chronic diseases associated with adopting a sedentary lifestyle are also to fuel the growth rate of the Cannabidiol Market in Europe. Moreover, the use of cannabidiol, in fact, reduces inflammation, anxiety, and acts as a sleeping aid, which also proved to lower the frequency of seizures. All these benefits are adding value to the CBD oil in the market. Along with this, rising investments in the development of new products using CBD oil by the government are leveraging this market's growth rate. Also, growing support from private organizations through funds is greatly influencing the demand of the market.
However, fluctuations in the availability of raw materials in the pharmaceutical companies are slowly impeding the demand of the market. The growing cost of the products is also hindering the growth rate of the market in Europe. In addition, the lack of proper knowledge over the use of CBD oil in various fields is quietly hampering the growth rate of the market. Increasing risk factors with the long-term use of medicinal products is degrading the growth rate of CBD oil in Europe.
This research report on the European Cannabidiol Market has been segmented & sub-segmented into the following categories:
By Type:
By Distribution Channel:
By End Users:
By Country:
Geographically, the European market is in the second top position in leading the highest shares of the market following North America. Increasing expenditure on healthcare with the rising disposable income in developed countries is likely to bolster the demand of the market. Increasing approvals from the government organizations for the new product launches are also leveling up the market’s growth.
The German Cannabidiol Market is the top leading country in holding the shares of the Cannabidiol Market. Rising awareness of the benefits of CBD oil in healthcare and growing prevalence to improve the quality of the treatment procedures are majorly fuelling the demand of the market in this country. Also, increasing funds from both public and private organizations are escalating the growth rate of the market. Besides, the rapid adoption of these products in pharmaceutical companies is creating growth opportunities for the market. The launch of innovative products in favor of the end-users and the introduction of reimbursement policies are promoting the market's growth rate.
In the UK market, the market shares are expected to grow at the highest CAGR in the coming years. Growing incidences of chronic diseases and the rising efficacy of CBD oil, which is derived from cannabis, are accelerating the demand of the market.
Companies dominating the European Cannabidiol Market profiled in this report are Pharmahemp d.o.o, ENDOCA, NuLeaf Naturals LLC, Folium Biosciences, Elixinol, Cannoid LLC, Medical Marijuana Inc., and Isodiol International Inc.
1. Introduction
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferencees
4. Market Dynamics
4.1 Impact Analysis
4.1.1 Drivers
4.1.2 Restaints
4.1.3 Opportunities
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.2 Products/Service
5.1.3 Regional Presence
5.2 Mergers & Acquistion Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 CBD Oil Market, By Source Type
6.1.1 Marijuana
6.1.2 Hemp
6.1.3 Market Size Estimations & Forecasts (2019-2024)
6.1.4 Y-o-Y Growth Rate Analysis
6.1.5 Market Attractiveness Index
6.2 CBD Oil Market, By Distribution Channel
6.2.1 B2C
6.2.2 B2B
6.2.3 Market Size Estimations & Forecasts (2019-2024)
6.2.4 Y-o-Y Growth Rate Analysis
6.2.5 Market Attractiveness Index
6.3 CBD Oil Market, By End-Use
6.3.1 Personal Care & Cosmetics
6.3.2 Food & Beverages
6.3.3 Pharmaceuticals
6.3.4 Market Size Estimations & Forecasts (2019-2024)
6.3.5 Y-o-Y Growth Rate Analysis
6.3.6 Market Attractiveness Index
7. Geographical Landscape
7.1 Global Identity Governance and Administration Market, by Region
7.2 Europe
7.2.1 By Country
7.2.1.1 UK
7.2.1.2 France
7.2.1.3 Germany
7.2.1.4 Spain
7.2.1.5 Italy
7.2.1.6 Rest of Europe
7.2.2 By Source Type
7.2.3 By Distribution Channel
7.2.4 By End-Use
8. Key Player Analysis
8.1 Pharmahemp d.o.o
8.1.1 Business Description
8.1.2 Products/Service
8.1.3 Financials
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 ENDOCA
8.3 NuLeaf Naturals LLC
8.4 Folium Biosciences
8.5 Elixinol
8.6 Cannoid LLC
8.7 Medical Marijuana Inc
8.8 Isodiol International Inc
9. Market Outlook & Investment Opportunities
Appendix
List of Tables
List of Figures
Related Reports
Aug 2021
Jan 2021
